statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HOUSTON, April 04, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending for the development...

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- FibroBiologics (Nasdaq: FBLG) ( FibroBiologics ), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

FibroBiologics reports encouraging early data for diabetes cell therapy...

FibroBiologics reports encouraging early data for diabetes cell therapy

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment PR Newswire...

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FibroBiologics to Present at Advanced Wound Care Summit USA FibroBiologics to Present at Advanced Wound Care Summit USA PR Newswire HOUSTON, March 13, 2024 HOUSTON, March 13, 2024 /PRNewswire...

FibroBiologics to Present at Advanced Wound Care Summit USA

FibroBiologics Appoints Ruben A. Garcia as General Counsel FibroBiologics Appoints Ruben A. Garcia as General Counsel PR Newswire HOUSTON, March 6, 2024 HOUSTON, March 6, 2024 /PRNewswire...

FibroBiologics Appoints Ruben A. Garcia as General Counsel

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Fibrobiologics Inc trading halted, volatility trading pause

FibroBiologics Files 2023 Form 10-K Annual Report FibroBiologics Files 2023 Form 10-K Annual Report PR Newswire HOUSTON, Feb. 29, 2024 HOUSTON, Feb. 29, 2024 /PRNewswire/ -- FibroBiologics, Inc...

FibroBiologics Files 2023 Form 10-K Annual Report

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum FibroBiologics to Present Preclinical and...

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.

Volume	11,288.00
52-Wk High	$55.00
52-Wk Low	$6.53

FBLG FibroBiologics Inc

About

Feed

News

Sentiment

Fundamentals